ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RGLS Regulus Therapeutics Inc

1.96
0.07 (3.70%)
May 22 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 60.99M54.3M52.13M46.72M37.02M43.65M37.75M30.75M
Total Current Assets 57.93M51.4M49.37M44.08M34.56M41.36M35.08M28.18M
Cash and Equivalents 53.9M35.12M20.01M24.23M30.31M37.26M25.83M23.77M
Total Non-Current Assets 3.05M2.9M2.75M3.17M2.45M2.28M2.67M3.63M
Total Liabilities 11.74M11.93M12.46M13.43M10.42M9.65M9.49M9.56M
Total Current Liabilities 4.7M5.83M10.52M11.66M8.82M8.23M8.25M8.51M
Total Non-Current Liabilities 10.63M8.9M1.94M1.77M1.6M1.42M1.24M1.06M
Common Equity 151k20k22k22k22k24k25k25k
Retained Earnings -461.57M-468.83M-476.38M-483.18M-490.32M-497.33M-505.15M-513.21M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 100.66M77.81M27.93M42.08M37.6M68.45M46.72M30.75M
Total Current Assets 87.47M66.74M19.3M40.41M36.73M65.24M44.08M28.18M
Cash and Equivalents 14.94M13.52M13.94M34.12M31.09M60.38M24.23M23.77M
Total Non-Current Assets 56.08M35.22M-5.85M20.02M26.03M54.96M33.29M21.19M
Total Liabilities 44.59M42.59M33.78M22.07M11.58M13.5M13.43M9.56M
Total Current Liabilities 13.81M32.6M26.65M21.6M11.58M5.23M11.66M8.51M
Total Non-Current Liabilities 50.58M9.99M7.14M468k012.94M1.77M1.06M
Total Equity 56.08M35.22M-5.85M20.02M26.03M54.96M33.29M21.19M
Common Equity 53k104k9k25k69k151k22k25k
Retained Earnings -273.35M-345.86M-392.72M-411.32M-427.05M-454.85M-483.18M-513.21M

Your Recent History

Delayed Upgrade Clock